 | • レポートコード：QYR2104Z1445 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、91ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療 |
| Single User | ￥546,000 (USD3,900) | ▷ お問い合わせ |
| Multi User/Five User | ￥819,000 (USD5,850) | ▷ お問い合わせ |
| Enterprise License（同一法人内共有可） | ￥1,092,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査資料では、結腸・直腸がんのグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（結腸がん治療、直腸がん治療）、用途別市場規模（病院、クリニック）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・結腸・直腸がんの市場動向 ・企業の競争状況、市場シェア ・結腸・直腸がんの種類別市場規模（結腸がん治療、直腸がん治療） ・結腸・直腸がんの用途別市場規模（病院、クリニック） ・結腸・直腸がんの北米市場規模2016-2027（アメリカ、カナダ） ・結腸・直腸がんのヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・結腸・直腸がんのアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・結腸・直腸がんの中南米市場規模2016-2027（メキシコ、ブラジル） ・結腸・直腸がんの中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Pfizer、Bayer Healthcare、Spectrum、Novartis、Amgen、Roche、Merck） ・結論 |
Market Analysis and Insights: Global Colon & Rectal Carcinoma Market
The global Colon & Rectal Carcinoma market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Colon & Rectal Carcinoma market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Colon & Rectal Carcinoma market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Colon & Rectal Carcinoma market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Colon & Rectal Carcinoma market.
Global Colon & Rectal Carcinoma Scope and Market Size
Colon & Rectal Carcinoma market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Colon & Rectal Carcinoma market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Colon Carcinoma Treatment
Rectal Carcinoma Treatment
Segment by Application
Hospital
Clinic
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Pfizer
Bayer Healthcare
Spectrum
Novartis
Amgen
Roche
Merck
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Colon & Rectal Carcinoma Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Colon Carcinoma Treatment
1.2.3 Rectal Carcinoma Treatment
1.3 Market by Application
1.3.1 Global Colon & Rectal Carcinoma Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospital
1.3.3 Clinic
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Colon & Rectal Carcinoma Market Perspective (2016-2027)
2.2 Colon & Rectal Carcinoma Growth Trends by Regions
2.2.1 Colon & Rectal Carcinoma Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Colon & Rectal Carcinoma Historic Market Share by Regions (2016-2021)
2.2.3 Colon & Rectal Carcinoma Forecasted Market Size by Regions (2022-2027)
2.3 Colon & Rectal Carcinoma Industry Dynamic
2.3.1 Colon & Rectal Carcinoma Market Trends
2.3.2 Colon & Rectal Carcinoma Market Drivers
2.3.3 Colon & Rectal Carcinoma Market Challenges
2.3.4 Colon & Rectal Carcinoma Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Colon & Rectal Carcinoma Players by Revenue
3.1.1 Global Top Colon & Rectal Carcinoma Players by Revenue (2016-2021)
3.1.2 Global Colon & Rectal Carcinoma Revenue Market Share by Players (2016-2021)
3.2 Global Colon & Rectal Carcinoma Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Colon & Rectal Carcinoma Revenue
3.4 Global Colon & Rectal Carcinoma Market Concentration Ratio
3.4.1 Global Colon & Rectal Carcinoma Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Colon & Rectal Carcinoma Revenue in 2020
3.5 Colon & Rectal Carcinoma Key Players Head office and Area Served
3.6 Key Players Colon & Rectal Carcinoma Product Solution and Service
3.7 Date of Enter into Colon & Rectal Carcinoma Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Colon & Rectal Carcinoma Breakdown Data by Type
4.1 Global Colon & Rectal Carcinoma Historic Market Size by Type (2016-2021)
4.2 Global Colon & Rectal Carcinoma Forecasted Market Size by Type (2022-2027)
5 Colon & Rectal Carcinoma Breakdown Data by Application
5.1 Global Colon & Rectal Carcinoma Historic Market Size by Application (2016-2021)
5.2 Global Colon & Rectal Carcinoma Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Colon & Rectal Carcinoma Market Size (2016-2027)
6.2 North America Colon & Rectal Carcinoma Market Size by Type
6.2.1 North America Colon & Rectal Carcinoma Market Size by Type (2016-2021)
6.2.2 North America Colon & Rectal Carcinoma Market Size by Type (2022-2027)
6.2.3 North America Colon & Rectal Carcinoma Market Size by Type (2016-2027)
6.3 North America Colon & Rectal Carcinoma Market Size by Application
6.3.1 North America Colon & Rectal Carcinoma Market Size by Application (2016-2021)
6.3.2 North America Colon & Rectal Carcinoma Market Size by Application (2022-2027)
6.3.3 North America Colon & Rectal Carcinoma Market Size by Application (2016-2027)
6.4 North America Colon & Rectal Carcinoma Market Size by Country
6.4.1 North America Colon & Rectal Carcinoma Market Size by Country (2016-2021)
6.4.2 North America Colon & Rectal Carcinoma Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada
7 Europe
7.1 Europe Colon & Rectal Carcinoma Market Size (2016-2027)
7.2 Europe Colon & Rectal Carcinoma Market Size by Type
7.2.1 Europe Colon & Rectal Carcinoma Market Size by Type (2016-2021)
7.2.2 Europe Colon & Rectal Carcinoma Market Size by Type (2022-2027)
7.2.3 Europe Colon & Rectal Carcinoma Market Size by Type (2016-2027)
7.3 Europe Colon & Rectal Carcinoma Market Size by Application
7.3.1 Europe Colon & Rectal Carcinoma Market Size by Application (2016-2021)
7.3.2 Europe Colon & Rectal Carcinoma Market Size by Application (2022-2027)
7.3.3 Europe Colon & Rectal Carcinoma Market Size by Application (2016-2027)
7.4 Europe Colon & Rectal Carcinoma Market Size by Country
7.4.1 Europe Colon & Rectal Carcinoma Market Size by Country (2016-2021)
7.4.2 Europe Colon & Rectal Carcinoma Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Colon & Rectal Carcinoma Market Size (2016-2027)
8.2 Asia-Pacific Colon & Rectal Carcinoma Market Size by Type
8.2.1 Asia-Pacific Colon & Rectal Carcinoma Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Colon & Rectal Carcinoma Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Colon & Rectal Carcinoma Market Size by Type (2016-2027)
8.3 Asia-Pacific Colon & Rectal Carcinoma Market Size by Application
8.3.1 Asia-Pacific Colon & Rectal Carcinoma Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Colon & Rectal Carcinoma Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Colon & Rectal Carcinoma Market Size by Application (2016-2027)
8.4 Asia-Pacific Colon & Rectal Carcinoma Market Size by Region
8.4.1 Asia-Pacific Colon & Rectal Carcinoma Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Colon & Rectal Carcinoma Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Colon & Rectal Carcinoma Market Size (2016-2027)
9.2 Latin America Colon & Rectal Carcinoma Market Size by Type
9.2.1 Latin America Colon & Rectal Carcinoma Market Size by Type (2016-2021)
9.2.2 Latin America Colon & Rectal Carcinoma Market Size by Type (2022-2027)
9.2.3 Latin America Colon & Rectal Carcinoma Market Size by Type (2016-2027)
9.3 Latin America Colon & Rectal Carcinoma Market Size by Application
9.3.1 Latin America Colon & Rectal Carcinoma Market Size by Application (2016-2021)
9.3.2 Latin America Colon & Rectal Carcinoma Market Size by Application (2022-2027)
9.3.3 Latin America Colon & Rectal Carcinoma Market Size by Application (2016-2027)
9.4 Latin America Colon & Rectal Carcinoma Market Size by Country
9.4.1 Latin America Colon & Rectal Carcinoma Market Size by Country (2016-2021)
9.4.2 Latin America Colon & Rectal Carcinoma Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Colon & Rectal Carcinoma Market Size (2016-2027)
10.2 Middle East & Africa Colon & Rectal Carcinoma Market Size by Type
10.2.1 Middle East & Africa Colon & Rectal Carcinoma Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Colon & Rectal Carcinoma Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Colon & Rectal Carcinoma Market Size by Type (2016-2027)
10.3 Middle East & Africa Colon & Rectal Carcinoma Market Size by Application
10.3.1 Middle East & Africa Colon & Rectal Carcinoma Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Colon & Rectal Carcinoma Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Colon & Rectal Carcinoma Market Size by Application (2016-2027)
10.4 Middle East & Africa Colon & Rectal Carcinoma Market Size by Country
10.4.1 Middle East & Africa Colon & Rectal Carcinoma Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Colon & Rectal Carcinoma Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Pfizer
11.1.1 Pfizer Company Details
11.1.2 Pfizer Business Overview
11.1.3 Pfizer Colon & Rectal Carcinoma Introduction
11.1.4 Pfizer Revenue in Colon & Rectal Carcinoma Business (2016-2021)
11.1.5 Pfizer Recent Development
11.2 Bayer Healthcare
11.2.1 Bayer Healthcare Company Details
11.2.2 Bayer Healthcare Business Overview
11.2.3 Bayer Healthcare Colon & Rectal Carcinoma Introduction
11.2.4 Bayer Healthcare Revenue in Colon & Rectal Carcinoma Business (2016-2021)
11.2.5 Bayer Healthcare Recent Development
11.3 Spectrum
11.3.1 Spectrum Company Details
11.3.2 Spectrum Business Overview
11.3.3 Spectrum Colon & Rectal Carcinoma Introduction
11.3.4 Spectrum Revenue in Colon & Rectal Carcinoma Business (2016-2021)
11.3.5 Spectrum Recent Development
11.4 Novartis
11.4.1 Novartis Company Details
11.4.2 Novartis Business Overview
11.4.3 Novartis Colon & Rectal Carcinoma Introduction
11.4.4 Novartis Revenue in Colon & Rectal Carcinoma Business (2016-2021)
11.4.5 Novartis Recent Development
11.5 Amgen
11.5.1 Amgen Company Details
11.5.2 Amgen Business Overview
11.5.3 Amgen Colon & Rectal Carcinoma Introduction
11.5.4 Amgen Revenue in Colon & Rectal Carcinoma Business (2016-2021)
11.5.5 Amgen Recent Development
11.6 Roche
11.6.1 Roche Company Details
11.6.2 Roche Business Overview
11.6.3 Roche Colon & Rectal Carcinoma Introduction
11.6.4 Roche Revenue in Colon & Rectal Carcinoma Business (2016-2021)
11.6.5 Roche Recent Development
11.7 Merck
11.7.1 Merck Company Details
11.7.2 Merck Business Overview
11.7.3 Merck Colon & Rectal Carcinoma Introduction
11.7.4 Merck Revenue in Colon & Rectal Carcinoma Business (2016-2021)
11.7.5 Merck Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Colon & Rectal Carcinoma Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Colon Carcinoma Treatment
Table 3. Key Players of Rectal Carcinoma Treatment
Table 4. Global Colon & Rectal Carcinoma Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 5. Global Colon & Rectal Carcinoma Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Colon & Rectal Carcinoma Market Size by Regions (2016-2021) & (US$ Million)
Table 7. Global Colon & Rectal Carcinoma Market Share by Regions (2016-2021)
Table 8. Global Colon & Rectal Carcinoma Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 9. Global Colon & Rectal Carcinoma Market Share by Regions (2022-2027)
Table 10. Colon & Rectal Carcinoma Market Trends
Table 11. Colon & Rectal Carcinoma Market Drivers
Table 12. Colon & Rectal Carcinoma Market Challenges
Table 13. Colon & Rectal Carcinoma Market Restraints
Table 14. Global Colon & Rectal Carcinoma Revenue by Players (2016-2021) & (US$ Million)
Table 15. Global Colon & Rectal Carcinoma Market Share by Players (2016-2021)
Table 16. Global Top Colon & Rectal Carcinoma Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Colon & Rectal Carcinoma as of 2020)
Table 17. Ranking of Global Top Colon & Rectal Carcinoma Companies by Revenue (US$ Million) in 2020
Table 18. Global 5 Largest Players Market Share by Colon & Rectal Carcinoma Revenue (CR5 and HHI) & (2016-2021)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Colon & Rectal Carcinoma Product Solution and Service
Table 21. Date of Enter into Colon & Rectal Carcinoma Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Colon & Rectal Carcinoma Market Size by Type (2016-2021) (US$ Million)
Table 24. Global Colon & Rectal Carcinoma Revenue Market Share by Type (2016-2021)
Table 25. Global Colon & Rectal Carcinoma Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 26. Global Colon & Rectal Carcinoma Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 27. Global Colon & Rectal Carcinoma Market Size Share by Application (2016-2021) & (US$ Million)
Table 28. Global Colon & Rectal Carcinoma Revenue Market Share by Application (2016-2021)
Table 29. Global Colon & Rectal Carcinoma Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 30. Global Colon & Rectal Carcinoma Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 31. North America Colon & Rectal Carcinoma Market Size by Type (2016-2021) (US$ Million)
Table 32. North America Colon & Rectal Carcinoma Market Size by Type (2022-2027) & (US$ Million)
Table 33. North America Colon & Rectal Carcinoma Market Size by Application (2016-2021) (US$ Million)
Table 34. North America Colon & Rectal Carcinoma Market Size by Application (2022-2027) & (US$ Million)
Table 35. North America Colon & Rectal Carcinoma Market Size by Country (2016-2021) & (US$ Million)
Table 36. North America Colon & Rectal Carcinoma Market Size by Country (2022-2027) & (US$ Million)
Table 37. Europe Colon & Rectal Carcinoma Market Size by Type (2016-2021) (US$ Million)
Table 38. Europe Colon & Rectal Carcinoma Market Size by Type (2022-2027) & (US$ Million)
Table 39. Europe Colon & Rectal Carcinoma Market Size by Application (2016-2021) (US$ Million)
Table 40. Europe Colon & Rectal Carcinoma Market Size by Application (2022-2027) & (US$ Million)
Table 41. Europe Colon & Rectal Carcinoma Market Size by Country (2016-2021) & (US$ Million)
Table 42. Europe Colon & Rectal Carcinoma Market Size by Country (2022-2027) & (US$ Million)
Table 43. Asia-Pacific Colon & Rectal Carcinoma Market Size by Type (2016-2021) (US$ Million)
Table 44. Asia-Pacific Colon & Rectal Carcinoma Market Size by Type (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Colon & Rectal Carcinoma Market Size by Application (2016-2021) (US$ Million)
Table 46. Asia-Pacific Colon & Rectal Carcinoma Market Size by Application (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Colon & Rectal Carcinoma Market Size by Region (2016-2021) & (US$ Million)
Table 48. Asia-Pacific Colon & Rectal Carcinoma Market Size by Region (2022-2027) & (US$ Million)
Table 49. Latin America Colon & Rectal Carcinoma Market Size by Type (2016-2021) (US$ Million)
Table 50. Latin America Colon & Rectal Carcinoma Market Size by Type (2022-2027) & (US$ Million)
Table 51. Latin America Colon & Rectal Carcinoma Market Size by Application (2016-2021) (US$ Million)
Table 52. Latin America Colon & Rectal Carcinoma Market Size by Application (2022-2027) & (US$ Million)
Table 53. Latin America Colon & Rectal Carcinoma Market Size by Country (2016-2021) & (US$ Million)
Table 54. Latin America Colon & Rectal Carcinoma Market Size by Country (2022-2027) & (US$ Million)
Table 55. Middle East & Africa Colon & Rectal Carcinoma Market Size by Type (2016-2021) (US$ Million)
Table 56. Middle East & Africa Colon & Rectal Carcinoma Market Size by Type (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Colon & Rectal Carcinoma Market Size by Application (2016-2021) (US$ Million)
Table 58. Middle East & Africa Colon & Rectal Carcinoma Market Size by Application (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Colon & Rectal Carcinoma Market Size by Country (2016-2021) & (US$ Million)
Table 60. Middle East & Africa Colon & Rectal Carcinoma Market Size by Country (2022-2027) & (US$ Million)
Table 61. Pfizer Company Details
Table 62. Pfizer Business Overview
Table 63. Pfizer Colon & Rectal Carcinoma Product
Table 64. Pfizer Revenue in Colon & Rectal Carcinoma Business (2016-2021) & (US$ Million)
Table 65. Pfizer Recent Development
Table 66. Bayer Healthcare Company Details
Table 67. Bayer Healthcare Business Overview
Table 68. Bayer Healthcare Colon & Rectal Carcinoma Product
Table 69. Bayer Healthcare Revenue in Colon & Rectal Carcinoma Business (2016-2021) & (US$ Million)
Table 70. Bayer Healthcare Recent Development
Table 71. Spectrum Company Details
Table 72. Spectrum Business Overview
Table 73. Spectrum Colon & Rectal Carcinoma Product
Table 74. Spectrum Revenue in Colon & Rectal Carcinoma Business (2016-2021) & (US$ Million)
Table 75. Spectrum Recent Development
Table 76. Novartis Company Details
Table 77. Novartis Business Overview
Table 78. Novartis Colon & Rectal Carcinoma Product
Table 79. Novartis Revenue in Colon & Rectal Carcinoma Business (2016-2021) & (US$ Million)
Table 80. Novartis Recent Development
Table 81. Amgen Company Details
Table 82. Amgen Business Overview
Table 83. Amgen Colon & Rectal Carcinoma Product
Table 84. Amgen Revenue in Colon & Rectal Carcinoma Business (2016-2021) & (US$ Million)
Table 85. Amgen Recent Development
Table 86. Roche Company Details
Table 87. Roche Business Overview
Table 88. Roche Colon & Rectal Carcinoma Product
Table 89. Roche Revenue in Colon & Rectal Carcinoma Business (2016-2021) & (US$ Million)
Table 90. Roche Recent Development
Table 91. Merck Company Details
Table 92. Merck Business Overview
Table 93. Merck Colon & Rectal Carcinoma Product
Table 94. Merck Revenue in Colon & Rectal Carcinoma Business (2016-2021) & (US$ Million)
Table 95. Merck Recent Development
Table 96. Research Programs/Design for This Report
Table 97. Key Data Information from Secondary Sources
Table 98. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Colon & Rectal Carcinoma Market Share by Type: 2020 VS 2027
Figure 2. Colon Carcinoma Treatment Features
Figure 3. Rectal Carcinoma Treatment Features
Figure 4. Global Colon & Rectal Carcinoma Market Share by Application: 2020 VS 2027
Figure 5. Hospital Case Studies
Figure 6. Clinic Case Studies
Figure 7. Colon & Rectal Carcinoma Report Years Considered
Figure 8. Global Colon & Rectal Carcinoma Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 9. Global Colon & Rectal Carcinoma Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 10. Global Colon & Rectal Carcinoma Market Share by Regions: 2020 VS 2027
Figure 11. Global Colon & Rectal Carcinoma Market Share by Regions (2022-2027)
Figure 12. Global Colon & Rectal Carcinoma Market Share by Players in 2020
Figure 13. Global Top Colon & Rectal Carcinoma Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Colon & Rectal Carcinoma as of 2020
Figure 14. The Top 10 and 5 Players Market Share by Colon & Rectal Carcinoma Revenue in 2020
Figure 15. Global Colon & Rectal Carcinoma Revenue Market Share by Type (2016-2021)
Figure 16. Global Colon & Rectal Carcinoma Revenue Market Share by Type (2022-2027)
Figure 17. North America Colon & Rectal Carcinoma Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 18. North America Colon & Rectal Carcinoma Market Share by Type (2016-2027)
Figure 19. North America Colon & Rectal Carcinoma Market Share by Application (2016-2027)
Figure 20. North America Colon & Rectal Carcinoma Market Share by Country (2016-2027)
Figure 21. United States Colon & Rectal Carcinoma Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 22. Canada Colon & Rectal Carcinoma Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. Europe Colon & Rectal Carcinoma Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Europe Colon & Rectal Carcinoma Market Share by Type (2016-2027)
Figure 25. Europe Colon & Rectal Carcinoma Market Share by Application (2016-2027)
Figure 26. Europe Colon & Rectal Carcinoma Market Share by Country (2016-2027)
Figure 27. Germany Colon & Rectal Carcinoma Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. France Colon & Rectal Carcinoma Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. U.K. Colon & Rectal Carcinoma Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. Italy Colon & Rectal Carcinoma Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. Russia Colon & Rectal Carcinoma Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Nordic Colon & Rectal Carcinoma Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Asia-Pacific Colon & Rectal Carcinoma Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Asia-Pacific Colon & Rectal Carcinoma Market Share by Type (2016-2027)
Figure 35. Asia-Pacific Colon & Rectal Carcinoma Market Share by Application (2016-2027)
Figure 36. Asia-Pacific Colon & Rectal Carcinoma Market Share by Region (2016-2027)
Figure 37. China Colon & Rectal Carcinoma Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Japan Colon & Rectal Carcinoma Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. South Korea Colon & Rectal Carcinoma Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Southeast Asia Colon & Rectal Carcinoma Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. India Colon & Rectal Carcinoma Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Australia Colon & Rectal Carcinoma Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Latin America Colon & Rectal Carcinoma Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Latin America Colon & Rectal Carcinoma Market Share by Type (2016-2027)
Figure 45. Latin America Colon & Rectal Carcinoma Market Share by Application (2016-2027)
Figure 46. Latin America Colon & Rectal Carcinoma Market Share by Country (2016-2027)
Figure 47. Mexico Colon & Rectal Carcinoma Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Brazil Colon & Rectal Carcinoma Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Middle East & Africa Colon & Rectal Carcinoma Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Middle East & Africa Colon & Rectal Carcinoma Market Share by Type (2016-2027)
Figure 51. Middle East & Africa Colon & Rectal Carcinoma Market Share by Application (2016-2027)
Figure 52. Middle East & Africa Colon & Rectal Carcinoma Market Share by Country (2016-2027)
Figure 53. Turkey Colon & Rectal Carcinoma Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Saudi Arabia Colon & Rectal Carcinoma Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. UAE Colon & Rectal Carcinoma Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Pfizer Revenue Growth Rate in Colon & Rectal Carcinoma Business (2016-2021)
Figure 57. Bayer Healthcare Revenue Growth Rate in Colon & Rectal Carcinoma Business (2016-2021)
Figure 58. Spectrum Revenue Growth Rate in Colon & Rectal Carcinoma Business (2016-2021)
Figure 59. Novartis Revenue Growth Rate in Colon & Rectal Carcinoma Business (2016-2021)
Figure 60. Amgen Revenue Growth Rate in Colon & Rectal Carcinoma Business (2016-2021)
Figure 61. Roche Revenue Growth Rate in Colon & Rectal Carcinoma Business (2016-2021)
Figure 62. Merck Revenue Growth Rate in Colon & Rectal Carcinoma Business (2016-2021)
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed
世界の副腎皮質がん治療市場規模・現状・予測（2021年-2027年） Adrenocortical carcinoma (ACC) is a rare disease caused by cancerous growth in the adrenal cortex, which is the outer layer of the adrenal glands. The adrenal glands lie on top of the kidneys. They play a major role in the endocrine system, which is the system that produces and regulates hormones. T…- 世界の副腎皮質がん治療市場規模・現状・予測（2021年-2027年） Adrenocortical carcinoma (ACC) is a rare disease caused by cancerous growth in the adrenal cortex, which is the outer layer of the adrenal glands. The adrenal glands lie on top of the kidneys. They play a major role in the endocrine system, which is the system that produces and regulates hormones. T…
- 世界の基底細胞がん治療市場規模・現状・予測（2021年-2027年） Basal cell carcinoma (BCC) is the most common type of skin cancer. It’s also the most commonly diagnosed cancer in the United States. Every year, millions of people learn that they have BCC. Basal cell carcinoma that is superficial and doesn't extend very far into the skin may be treated with creams…
- 世界の尿路上皮がん治療市場規模・現状・予測（2021年-2027年） Urothelial carcinoma is also called as transitional cell carcinoma which is a cancerous tumor of the bladder that can spread to other parts of the body. These are also called as malignant tumors. This tumor can start at any part of the urinary tract. People with bladder cancer may also have similar …
- 世界のメルケル細胞癌治療市場規模・現状・予測（2021年-2027年） Merkel cell carcinoma (MCC) is a rare and aggressive neuroendocrine tumor of the skin. Market Analysis and Insights: Global Merkel Cell Carcinoma Therapeutics Market The global Merkel Cell Carcinoma Therapeutics market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, a…